Search
00
GBAF Logo
trophy
Top StoriesInterviewsBusinessFinanceBankingTechnologyInvestingTradingVideosAwardsMagazinesHeadlinesTrends

Subscribe to our newsletter

Get the latest news and updates from our team.

Global Banking & Finance Review®

Global Banking & Finance Review® - Subscribe to our newsletter

Company

    GBAF Logo
    • About Us
    • Advertising and Sponsorship
    • Profile & Readership
    • Contact Us
    • Latest News
    • Privacy & Cookies Policies
    • Terms of Use
    • Advertising Terms
    • Issue 81
    • Issue 80
    • Issue 79
    • Issue 78
    • Issue 77
    • Issue 76
    • Issue 75
    • Issue 74
    • Issue 73
    • Issue 72
    • Issue 71
    • Issue 70
    • View All
    • About the Awards
    • Awards Timetable
    • Awards Winners
    • Submit Nominations
    • Testimonials
    • Media Room
    • FAQ
    • Asset Management Awards
    • Brand of the Year Awards
    • Business Awards
    • Cash Management Banking Awards
    • Banking Technology Awards
    • CEO Awards
    • Customer Service Awards
    • CSR Awards
    • Deal of the Year Awards
    • Corporate Governance Awards
    • Corporate Banking Awards
    • Digital Transformation Awards
    • Fintech Awards
    • Education & Training Awards
    • ESG & Sustainability Awards
    • ESG Awards
    • Forex Banking Awards
    • Innovation Awards
    • Insurance & Takaful Awards
    • Investment Banking Awards
    • Investor Relations Awards
    • Leadership Awards
    • Islamic Banking Awards
    • Real Estate Awards
    • Project Finance Awards
    • Process & Product Awards
    • Telecommunication Awards
    • HR & Recruitment Awards
    • Trade Finance Awards
    • The Next 100 Global Awards
    • Wealth Management Awards
    • Travel Awards
    • Years of Excellence Awards
    • Publishing Principles
    • Ownership & Funding
    • Corrections Policy
    • Editorial Code of Ethics
    • Diversity & Inclusion Policy
    • Fact Checking Policy
    Original content: Global Banking and Finance Review - https://www.globalbankingandfinance.com

    A global financial intelligence and recognition platform delivering authoritative insights, data-driven analysis, and institutional benchmarking across Banking, Capital Markets, Investment, Technology, and Financial Infrastructure.

    Copyright © 2010-2026 - All Rights Reserved. | Sitemap | Tags

    Editorial & Advertiser disclosure

    Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

    1. Home
    2. >Finance
    3. >Julius Baer CEO tops highest pay at UBS
    Finance

    Julius baer CEO tops highest pay at UBS

    Published by Global Banking & Finance Review®

    Posted on March 16, 2026

    1 min read

    Last updated: March 16, 2026

    Julius Baer CEO tops highest pay at UBS - Finance news and analysis from Global Banking & Finance Review
    Tags:FinanceBankingExecutive Compensation

    Quick Summary

    Julius Baer CEO Stefan Bollinger received CHF 23.96 million in total compensation for 2025, topping UBS’s CEO Sergio Ermotti at CHF 14.9 million. Novartis’s CEO Vasant Narasimhan earned CHF 24.9 million, drawing proxy advisor Ethos’s criticism.

    Table of Contents

    • Executive Compensation in Swiss Banking Sector
    • Julius Baer CEO Stefan Bollinger's 2025 Compensation Details
    • Bollinger's Transition from Goldman Sachs
    • Comparison with UBS and Other Swiss Executives
    • UBS CEO Sergio Ermotti's Compensation
    • Novartis CEO Vasant Narasimhan's Compensation
    • Currency Exchange Rate Reference
    • Reporting Credits

    Julius Baer CEO Stefan Bollinger Receives Record Compensation, Surpassing UBS

    Executive Compensation in Swiss Banking Sector

    Julius Baer CEO Stefan Bollinger's 2025 Compensation Details

    ZURICH, March 16 (Reuters) - Julius Baer CEO Stefan Bollinger was awarded a total compensation of 23.96 million Swiss francs ($30.31 million) for 2025, a sum that includes replacement awards for forfeited variable pay of a previous employer, the Swiss bank said on Monday.

    Bollinger's Transition from Goldman Sachs

    Bollinger joined Julius Baer in January 2025 from Goldman Sachs. Bollinger's total salary at Julius Baer last year excluding replacements was 8.27 million Swiss francs, according to the bank's annual report.

    Comparison with UBS and Other Swiss Executives

    UBS CEO Sergio Ermotti's Compensation

    UBS, Switzerland's biggest bank, earlier this month kept CEO Sergio Ermotti's total compensation steady at 14.9 million Swiss francs amid an ongoing overhaul of Swiss banking rules and criticism of high bonuses for CEOs.

    Novartis CEO Vasant Narasimhan's Compensation

    Swiss pharma giant Novartis' CEO Vasant Narasimhan received a 24.9 million franc compensation package for 2025, which proxy advisory firm Ethos has called "particularly excessive".

    Currency Exchange Rate Reference

    ($1 = 0.7904 Swiss francs)

    Reporting Credits

    (Reporting by Ariane LuthiEditing by Ludwig Burger)

    Key Takeaways

    • •Stefan Bollinger’s 2025 pay includes replacement awards for forfeited variable pay from Goldman Sachs, totaling CHF 23.96 million, while his regular Julius Baer salary was CHF 8.27 million.
    • •UBS CEO Sergio Ermotti’s compensation held steady at CHF 14.9 million in 2025 amid political scrutiny of banker pay, despite a 10% rise in UBS’s overall bonus pool.
    • •Novartis CEO Vasant Narasimhan earned CHF 24.9 million in 2025—over 50% above the Swiss large-cap CEO median—prompting Ethos to call it “particularly excessive.”

    Frequently Asked Questions about Julius Baer CEO tops highest pay at UBS

    1How much was Julius Baer CEO Stefan Bollinger paid in 2025?

    Stefan Bollinger received a total compensation of 23.96 million Swiss francs in 2025.

    2What portion of Bollinger’s compensation was replacement awards?

    The total includes replacement awards for forfeited variable pay from his previous employer.

    3How does Julius Baer CEO’s compensation compare to the UBS CEO?

    Julius Baer CEO received 23.96 million francs, surpassing the UBS CEO’s 14.9 million francs.

    4Why did Julius Baer pay Bollinger replacement awards?

    Bollinger joined from Goldman Sachs and was compensated for forfeited pay from his previous employer.

    5What was UBS CEO Sergio Ermotti’s compensation in 2025?

    UBS CEO Sergio Ermotti’s total compensation was steady at 14.9 million Swiss francs in 2025.

    Why waste money on news and opinion when you can access them for free?

    Take advantage of our newsletter subscription and stay informed on the go!

    Subscribe

    More from Finance

    Explore more articles in the Finance category

    Image for UK's Marshalls slashes dividend as weakness in landscaping unit drags annual profit
    UK's marshalls slashes dividend as weakness in landscaping unit drags annual profit
    Image for European shares rise as Commerzbank climbs on UniCredit bid; defence stocks up
    European shares rise as commerzbank climbs on UniCredit bid; defence stocks up
    Image for EU's Kallas floats Black Sea model to unblock Strait of Hormuz
    EU's kallas floats black sea model to unblock strait of hormuz
    Image for GN Store Nord to sell hearing business to Amplifon for $2.6 billion
    GN store nord to sell hearing business to amplifon for $2.6 billion
    Image for Russia gold producer Polyus' 2025 pretax profit climbs 12% to $6.3 billion
    Russia gold producer polyus' 2025 pretax profit climbs 12% to $6.3 billion
    Image for UniCredit launches offer to own more than 30% of Commerzbank without taking control
    UniCredit launches offer to own more than 30% of commerzbank without taking control
    Image for Thames Water lenders offer $4.4 billion in new equity to rescue utility
    Thames water lenders offer $4.4 billion in new equity to rescue utility
    Image for UK's Standard Life beats profit estimates on strength in pensions and savings business
    UK's standard life beats profit estimates on strength in pensions and savings business
    Image for UniCredit makes takeover bid for Commerzbank
    UniCredit makes takeover bid for commerzbank
    Image for Hedge fund Palliser says Korean investors starting to embrace shareholder activism
    Hedge fund palliser says Korean investors starting to embrace shareholder activism
    Image for British teens resist Australian-style social media ban
    British teens resist australian-style social media ban
    Image for Analysis-Middle East war disrupts pharma air routes, risks cancer drugs supply
    Analysis-Middle east war disrupts pharma air routes, risks cancer drugs supply
    View All Finance Posts
    Previous Finance PostBritish teens resist australian-style social media ban
    Next Finance PostAnalysis-Middle east war disrupts pharma air routes, risks cancer drugs supply